Anebulo Pharmaceuticals, Inc.
ANEB
$2.30
-$0.01-0.43%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 11.63M | 13.28M | 15.00M | 1.40M | 3.09M |
| Total Receivables | 73.20K | -- | 30.80K | 245.40K | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 261.40K | 528.00K | 366.30K | 312.90K | 413.80K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 11.96M | 13.81M | 15.40M | 1.96M | 3.51M |
|
|
|||||
| Total Current Assets | 11.96M | 13.81M | 15.40M | 1.96M | 3.51M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 183.10K | 200.50K | 445.70K | 505.40K | 565.10K |
| Total Assets | 12.15M | 14.01M | 15.84M | 2.47M | 4.07M |
|
|
|||||
| Total Accounts Payable | 224.20K | 427.60K | 319.50K | 252.10K | 156.40K |
| Total Accrued Expenses | 263.50K | 118.50K | 559.30K | 317.10K | 104.20K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 487.70K | 546.00K | 878.80K | 569.20K | 260.60K |
|
|
|||||
| Total Current Liabilities | 487.70K | 546.00K | 878.80K | 569.20K | 260.60K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 487.70K | 546.00K | 878.80K | 569.20K | 260.60K |
|
|
|||||
| Common Stock & APIC | 85.55M | 85.21M | 85.03M | 69.50M | 69.22M |
| Retained Earnings | -73.89M | -71.74M | -70.07M | -67.60M | -65.40M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 11.66M | 13.46M | 14.96M | 1.90M | 3.81M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 11.66M | 13.46M | 14.96M | 1.90M | 3.81M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 11.66M | 13.46M | 14.96M | 1.90M | 3.81M |
|
|
|||||